Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Harbour BioMed Reports Full Year 2023 Financial Results 2024-03-28 22:10
Nona Biosciences Enters into Collaboration Agreement with Boostimmune in Antibody-Drug Conjugate Development 2024-02-27 09:23
Harbour BioMed Announces IND Clearance for HBM9027 in the U.S. 2024-01-24 12:40
Harbour BioMed Announces Positive Profit Alert 2024-01-19 12:52
Nona Biosciences Enters into a Global License Agreement with Pfizer for HBM9033, an MSLN-Targeted Antibody-Drug Conjugate (ADC) 2023-12-15 07:30
Harbour BioMed Announces 2023 Interim Results 2023-08-28 17:08
Harbour BioMed Announces US IND Clearance of Its First ADC Program HBM9033 in Solid Tumors 2023-08-28 16:30
Harbour BioMed Appoints Dr. Albert R. Collinson as Independent Non-Executive Director 2023-08-08 16:10
Harbour BioMed Announces 2023 Interim Results Positive Profit Alert with the Enhancement of Value Driven by Innovation 2023-07-13 18:11
Harbour BioMed Announces Biologics License Application Acceptance of Batoclimab for Treatment of Generalized Myasthenia Gravis by NMPA 2023-06-29 21:26
Nona Biosciences Appoints Steve Arkinstall, D. Phil., as Chief Scientific Advisor 2023-06-07 09:00
Harbour BioMed Announces First Patient Dosed in Phase I Study of First-in-Class Anti-B7H7 (HHLA2) Antibody HBM1020 2023-06-05 09:01
Harbour BioMed Reports Results of Phase Ib Clinical Trial of Porustobart in Combination of Toripalimab in Patients with Hepatocellular Carcinoma at ASCO 2023 2023-05-29 09:42
Nona Biosciences Announces Strategic Collaboration Agreement with PharmaEssentia Innovation Research Center 2023-05-12 09:32
Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses 2023-04-19 08:45
Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio 2023-04-06 10:20
Harbour BioMed Reports Full Year 2022 Financial Results 2023-04-03 15:10
Harbour BioMed Announces Positive Topline Results from Phase III Trial of Batoclimab for Treatment of Generalized Myasthenia Gravis 2023-03-06 14:27
HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders 2023-01-26 09:22
Nona Biosciences Enters into HCAb Based Drug Discovery Collaboration Agreement with Dragonfly Therapeutics 2022-11-21 17:31
1 2 3